Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ACHIEVE LIFE SCIENCES, INC. Director's Dealing 2023

Jan 27, 2023

33882_dirs_2023-01-27_d73fe227-004f-4620-9dbb-b41a89c2c724.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACHIEVE LIFE SCIENCES, INC. (ACHV)
CIK: 0000949858
Period of Report: 2023-01-25

Reporting Person: Bencich John (Director, CEO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-01-25 Performance Restricted Stock Unit (PRSU) $ A 100000 Acquired 2025-12-31 Common Stock (100000) Direct
2023-01-25 Stock Option (right to buy) $4.90 A 100000 Acquired 2033-01-25 Common Stock (100000) Direct

Footnotes

F1: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement.

F2: Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuers common stock that may ultimately vest range from 0% to 100% of the number of PRSUs initially granted, subject to certain milestones being met during the measurement period that begins on January 3, 2023 and ends on December 31, 2025.

F3: The options vest one-third on the first anniversary of January 25, 2023 and thereafter in monthly installments over 24 months.